409 related articles for article (PubMed ID: 20660127)
41. Fatty acids and sphingolipids profile in the blood plasma of experienced divers in response to hyperbaric exposure.
Chabowska AM; Radziwon BB; Lukaszuk B; Lipska A; Chabowski A; Kaczerska D; Siermontowski P; Radziwon P
Undersea Hyperb Med; 2018; 45():521-529. PubMed ID: 30428241
[TBL] [Abstract][Full Text] [Related]
42. Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.
Książek M; Baranowska U; Chabowski A; Baranowski M
Cell Physiol Biochem; 2018; 45(1):67-77. PubMed ID: 29316552
[TBL] [Abstract][Full Text] [Related]
43. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
44. Crosstalk between Serum and Skin Sphingolipids in Psoriasis.
Matwiejuk M; Myśliwiec H; Lukaszuk B; Lewoc M; Malla H; Myśliwiec P; Dadan J; Chabowski A; Flisiak I
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834321
[TBL] [Abstract][Full Text] [Related]
45. Sphingolipids in Atherosclerosis: Chimeras in Structure and Function.
Peters L; Kuebler WM; Simmons S
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233252
[TBL] [Abstract][Full Text] [Related]
46. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis-A Preliminary Study.
Zdanowicz K; Bobrus-Chcociej A; Pogodzinska K; Blachnio-Zabielska A; Zelazowska-Rutkowska B; Lebensztejn DM; Daniluk U
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233480
[TBL] [Abstract][Full Text] [Related]
47. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.
Bielawski J; Szulc ZM; Hannun YA; Bielawska A
Methods; 2006 Jun; 39(2):82-91. PubMed ID: 16828308
[TBL] [Abstract][Full Text] [Related]
48. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
[TBL] [Abstract][Full Text] [Related]
49. Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes.
Lopes-Virella MF; Hammad SM; Baker NL; Klein RL; Hunt KJ
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255295
[TBL] [Abstract][Full Text] [Related]
50. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.
Ohkawa R; Kurano M; Mishima Y; Nojiri T; Tokuhara Y; Kishimoto T; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Yokota H; Igarashi K; Ikeda H; Tozuka M; Yatomi Y
Clin Biochem; 2015 Jul; 48(10-11):690-7. PubMed ID: 25863111
[TBL] [Abstract][Full Text] [Related]
51. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
52. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
[TBL] [Abstract][Full Text] [Related]
53. Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.
Wątek M; Durnaś B; Wollny T; Pasiarski M; Góźdź S; Marzec M; Chabowska A; Wolak P; Żendzian-Piotrowska M; Bucki R
Lipids Health Dis; 2017 Dec; 16(1):235. PubMed ID: 29216917
[TBL] [Abstract][Full Text] [Related]
54. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
[TBL] [Abstract][Full Text] [Related]
55. HPLC-MS/MS Methods for Diacylglycerol and Sphingolipid Molecular Species in Skeletal Muscle.
Harrison KA; Bergman BC
Methods Mol Biol; 2019; 1978():137-152. PubMed ID: 31119661
[TBL] [Abstract][Full Text] [Related]
56. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
57. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.
Fretts AM; Jensen PN; Sitlani CM; Hoofnagle A; Lidgard B; Umans JG; Siscovick DS; King IB; Howard BV; Cole SA; Lemaitre RN
J Am Heart Assoc; 2024 Jun; ():e032536. PubMed ID: 38904223
[TBL] [Abstract][Full Text] [Related]
58. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
59. Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia.
Testai FD; Kilkus JP; Berdyshev E; Gorshkova I; Natarajan V; Dawson G
J Neurochem; 2014 Nov; 131(4):530-40. PubMed ID: 25060904
[TBL] [Abstract][Full Text] [Related]
60. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
Polzin A; Piayda K; Keul P; Dannenberg L; Mohring A; Gräler M; Zeus T; Kelm M; Levkau B
J Mol Cell Cardiol; 2017 Sep; 110():35-37. PubMed ID: 28709768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
